Iridium Complex Ligands for Narrow OLED Emission

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional organic light emitting diodes (OLEDs) face challenges in achieving stable and narrow emission lineshape for saturated colors, particularly in red, green, and blue pixels, which is crucial for full-color displays.

Innovation Solution

Development of novel Iridium complexes with ligands derived from imidazole- and benzimidazole dibenzofurans, substituted with cyclic groups and electron-withdrawing groups, which are used as emitters in OLEDs to enhance stability and emission characteristics.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional aza-dibenzofuran-based Iridium complexes are used as emitters, then the device can achieve basic emission function, but the emission lineshape is broad and stability is insufficient for saturated color display

Engineering Contradiction:
Improveemission lineshape precisionVSAvoidemitter stability
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

The patent modifies the ligand structure parameters by introducing cyclic groups at specific positions (X1-X8) and adding electron-withdrawing groups (Y), which changes the electronic and steric parameters of the complex to achieve narrower emission lineshape and improved stability simultaneously

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates composite ligand structures combining imidazole/benzimidazole dibenzofuran cores with cyclic substituents and electron-withdrawing groups, forming a multi-component molecular system that achieves both narrow emission and high stability

Inventive Principle:
Principle #40Composite materials

2Ease of manufacture

If the ligand structure is simplified for ease of synthesis, then manufacturing becomes easier, but emission lineshape precision and color saturation deteriorate

Engineering Contradiction:
Improveligand synthesis easeVSAvoidemission lineshape precision
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The ligand is divided into distinct functional segments: the dibenzofuran core (X1-X8), cyclic substituent groups (Ra, Rb, Rc), and electron-withdrawing groups (Y), allowing independent optimization of each segment for both synthesis ease and emission precision

Inventive Principle:
Principle #1Segmentation

3Adaptability or versatility

If broader emission lineshape is accepted for wider color gamut coverage, then device versatility improves, but color saturation and precision for specific wavelengths decrease

Engineering Contradiction:
Improvecolor gamut coverageVSAvoidemission lineshape precision
Core Design Contradiction:
Adaptability or versatilityVSManufacturing precision

Solution Approach 1:

The patent achieves narrow emission lineshape at specific target wavelengths (red, green, or blue) while maintaining the ability to tune other wavelengths, allowing saturated primary colors without sacrificing overall color gamut versatility

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The novel Iridium complexes provide more stable emitters with narrower emission lineshape compared to aza-dibenzofuran-based complexes, improving color accuracy and performance in OLEDs for display applications.

Implementation Method 1

For OLEDs, the organic materials may have performance advantages over conventional materials. OLEDs make use of thin organic films that emit light when voltage is applied across the device.

Methodology Applied
Scientific EffectPhosphorescence: Phosphorescence

Data Source

PatentUS20240090311A1Organic electroluminescent materials and devices
Publication Date: 2024.03.14 UNIVERSAL DISPLAY CORP
  • US20240090311A1 patent drawing
  • US20240090311A1 patent drawing
  • US20240090311A1 patent drawing

AI summary

A compound comprising a first ligand LA of Formula I,is provided. In Formula I, K is a direct bond, O, S, N(Rα), P(Rα), B(Rα), C(Rα)(Rβ), or Si(Rα)(Rβ); each of X1 to X8 is C or N; Y is a linking group; each Rα, Rβ, R, R′, R″, R1, RA, RB, and RC is hydrogen or a General Substituent; at least one RC is R*; R* has a structure of Cy-R**, where Cy is a monocyclic ring or a polycyclic fused ring system, which can be further substituted, and R** comprises (i) at least one electron-withdrawing group, (ii) a monocyclic ring or a polycyclic fused ring system, where the monocyclic ring and each ring of the polycyclic fused ring system is independently a 5-membered or 6-membered carbocyclic or heterocyclic ring, or (iii) both (i) and (ii); and LA is coordinated to a metal. Formulations, OLEDs, and consumer products containing the compound are also provided.